Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07764055
PHASE3

A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)

Sponsor: Medprin Regenerative Medical Technologies Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a multicenter, randomized, single-blind, positive-controlled, non-inferiority clinical trial. The purpose is to evaluate the safety and effectiveness of the absorbable multilayer fibrillar regenerated oxidized cellulose in controlling capillary, venous, and small arteriole bleeding during surgical procedures when ligation or other conventional methods are ineffective or impractical. A total of 288 subjects (144 in the test group, 144 in the control group) will be enrolled across 6 centers (General Surgery, Cardiothoracic Surgery, Gynecology, and Urology). Subjects will be followed up at 30±15 days and 180±30 days post-surgery. The primary efficacy endpoint is the hemostasis success rate within 5 minutes.

Official title: A Multicenter, Randomized, Single-Blind, Positive-Controlled Clinical Trial of Absorbable Multilayer Fibrillar Regenerated Oxidized Cellulose for Surgical Hemostasis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

288

Start Date

2022-11-09

Completion Date

2024-03-05

Last Updated

2026-08-13

Healthy Volunteers

No

Interventions

DEVICE

Absorbable Multilayer Fibrillar Regenerated Oxidized Cellulose

A sterile, absorbable, multilayer fibrillar regenerated oxidized cellulose dressing intended for use as an adjunctive hemostatic agent to control capillary, venous, and small arteriole bleeding during surgical procedures. The product is applied directly to the bleeding site and can be layered as needed. It is absorbed in the body over time.

DEVICE

SURGICEL Absorbable Hemostat (Absorbable Hemostatic Gauze)

A sterile, absorbable oxidized regenerated cellulose hemostatic dressing indicated for use as an adjunctive hemostatic agent to control capillary, venous, and small arteriole bleeding during surgical procedures. The product is applied directly to the bleeding site and is absorbed in the body.

Locations (6)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, China

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, China

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

Hangzhou, China

Zhejiang Provincial People's Hospital

Hangzhou, China

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, China